| BPN | bacitracin, polymyxin B, neomycin sulfate; brachial plexus neuropathy |
|---|---|
| PB | British pharmacopeia [Pharmacopoeia Britannica]; paraffin bath; Paul-Bunnell [antibody]; periodic br... |
| PBN | paralytic brachial neuritis; peripheral benign neoplasm; polymyxin B sulfate, bacitracin, and neomyc... |
| PLET | polymyxin, lysozyme, EDTA, and thallous acetate [in heart infusion agar] |
| PMB | papillomacular bundle; para-hydroxymercuribenzoate; polychrome methylene blue; polymorphonuclear bas... |
| PB | Polymyxin B |
|---|---|
| PMX-B | Polymyxin B |
| PXB | Polymyxin B |
| PMBN | Polymyxin B nonapeptide |
| polymyxin b | <chemical> A mixture of polymyxins b1 and b2, obtained from bacillus polymyxa strains. They are basic polypeptides of about eight amino acids and have cationic detergent action on cell membranes. Polymyxin b is used for infections with gram-negative organisms, but may be neurotoxic and nephrotoxic. Pharmacological action: antibiotics, peptide. Chemical name: Polymyxin B (12 Dec 1998) |
|---|---|
| polymyxin B sulfate | An antibacterial effective in tularaemia, brucellosis, Pseudomonas infections, and urinary tract infections, but used systemically only for severe infections not responsive to less toxic agents; it is also used locally. Polymyxin B is a mixture of polymyxin B1 and polymyxin B2. (05 Mar 2000) |
| polymyxin | <chemical> Basic polypeptide antibiotic group obtained from bacillus polymyxa. They affect the cell membrane by detergent action and may cause neuromuscular and kidney damage. at least eleven different members of the polymyxin group have been identified, each designated by a letter. Pharmacological action: antibiotics, peptide. (12 Dec 1998) |
|---|---|
| polymyxin acylase | <enzyme> Deacylates polymyxin, colistin and octapeptin antibiotic Registry number: EC 3.5.1.- (26 Jun 1999) |
Synonyms : Aerosporin, Polymyxin B Sulfate, Sulfate, Polymyxin B
| polymyxin B sulfate |
[USP] the sulfate salt of the least toxic member of the polymyxin group, occurring as a buff-colored powder; used in the treatment of various systemic, urinary tract, ophthalmic, otic, and cutaneous infections due to susceptible gram-negative bacteria, especially Pseudomonas aeruginosa, administered orally, parenterally, and topically.
출처: www.mercksource.com/pp/us/cns/cns_hl_dorlands.jspz...
|
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|